FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.

HYDERABAD: Dr Reddy’s Laboratories on Monday said it has expanded its strategic partnership with French biopharma giant ...

Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking ...

Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...

Under President Trump, the Food and Drug Administration may no longer approve seasonal COVID-19 vaccines updated for the ...

The news sent the stock of South San Francisco' Vaxart Inc. (Nasdaq: VXRT) nearly 17% higher Monday morning, or 6.7 cents, to ...

Changes to federal health websites have raised concerns about their reliability. These independent sources offer an ...

As safety flags hang over Valneva’s chikungunya vaccine in the U.S. and beyond, French authorities are clamping down on the shot’s use in older adults. | France’s public health agency has temporarily ...

For all the incompetence in the Trump administration, Secretary of Health and Human Services Robert Kennedy Jr. is causing ...

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...

The FDA has discussed with vaccine-maker Novavax the need for an additional trial of its COVID-19 vaccine as a post-approval ...